Navigation Links
Investigational agent targets gene signaling pathways to improve response for patients with CLL
Date:12/8/2012

uch patients are characterized by presence of chromosomal abnormalities (i.e., deletions of chromosome 17p or 11q) or short remissions (less than 3 years) after standard chemo-immunotherapy. To develop an alternative therapy regimen for this patient population, researchers explored the combination of ibrutinib and the anti-CD20 antibody rituximab in high-risk CLL.

In this Phase II study conducted at The University of Texas MD Anderson Cancer Center in Houston, ibrutinib was given in combination with rituximab to evaluate its potential to accelerate and improve CLL patient responses. Forty patients were treated with 420 mg of ibrutinib daily in combination with weekly rituximab for four weeks, followed by ibrutinib daily plus monthly rituximab until month six, followed by single-agent ibrutinib.

Positive responses to therapy were shown among the vast majority of treated patients. At four months of follow-up, the overall response rate was 85 percent and almost all (38 of 40) patients continued on therapy without disease progression. Of the 20 patients evaluable for early response, 17 achieved a partial remission. Patient health questionnaires also noted improvements in health and the quality of life of all treated patients.

Overall, the regimen was well-tolerated among participants, with little severe toxicity that was largely unrelated and short in duration. After treatment with ibrutinib-rituximab (iR) combination therapy, most cases of early lymphocytosis (increase in white blood cells that is a sign of infection), due to the ibrutinib-induced shift of CLL cells from lymph node tissues into the blood, peaked early and resolved; at four months of follow-up, only three treated patients had lymphocytosis that had not yet resolved. This shorter lymphocytosis duration, when compared to single-agent use of ibrutinib, is presumably related to the addition of rituximab.

"We know that high-risk CLL patients struggle with the effects of
'/>"/>

Contact: Andrea Slesinski
aslesinski@hematology.org
614-352-5096
American Society of Hematology
Source:Eurekalert

Page: 1 2 3 4 5 6

Related medicine news :

1. Updated Clinical Results Show Experimental Agent Ibrutinib as Highly Active in CLL Patients
2. Rilpivirine for HIV: Added benefit for single agent proven
3. Travel Services (MyTSOnline) in Valencia Teams Up With Vendors to Become the Number One Travel Agent in the Santa Clarita Valley
4. Mayo Clinic gets FDA approval for new imaging agent for recurrent prostate cancer
5. Scientists ID Cancer-Causing Agent in Smokeless Tobacco
6. Therapy combining exercise and neuroprotective agent shows promise for stroke victims
7. New substances 15,000 times more effective in destroying chemical warfare agents
8. Difficult to diagnose cases of infectious endocarditis solved with SPECT/CT imaging agent
9. Imaging agents predict breast cancer response to endocrine therapy
10. Pig stomach mucins are effective as anti-viral agents for consumer products
11. Method developed by VTT targets diagnosis of early Alzheimers disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... TopConsumerReviews.com recently awarded their highest ... in the relief of depression symptoms. ... sadness and depression each year and are unable ... prescription drugs can produce worse side effects than ... and require regular follow-up visits with a doctor. ...
(Date:11/21/2014)... (PRWEB) November 21, 2014 RankingBySEO has ... manage the online reputation of lawyers, and the company ... has announced the service for lawyers since it receives ... online reputation in big numbers. So far, the company ... and law firms in different parts of the world, ...
(Date:11/21/2014)... First Choice Emergency Room ... new facility is located at 225 E. Parkwood Drive, ... are pleased to join the Friendswood community and look ... here,” said Dr. Siddiqi, Facility Medical Director of First ... the opening, First Choice Emergency Room made a donation ...
(Date:11/21/2014)... November 21, 2014 M3 Global Research ... healthcare professional panel, today announced two important leadership changes to ... DasGupta as President of Market Research, Americas and the promotion ... , Ms. DasGupta joined M3 in 2011 and ... recently Head of Sales. Roni has over 17 years ...
(Date:11/21/2014)... Dennis Thompson HealthDay Reporter ... or obese women who get pregnant are much more likely ... an adult, new research suggests. But it looks like ... trend, the researchers added. "Mothers who are overweight teach ... Dr. Michael Mendelson. He is a research fellow at the ...
Breaking Medicine News(10 mins):Health News:Depression Relief Product Receives Top 5-Star Rating from TopConsumerReviews.com 2Health News:RankingBySEO Announces Lawyer Reputation Management Service 2Health News:First Choice Emergency Room Opens New Facility in Friendswood, Texas 2Health News:M3 Global Research Announces Leadership Team Promotions in US and EU 2Health News:Kids Born to Overweight Moms May Face Higher Heart Risks as Adults 2
... stillbirths of rodents born to mothers infected with cytomegalovirus// ... loss in newborn children infected in early fetal life. ... ,Estimates place the number of U.S. children born ... is no vaccine or treatment for pregnant women who ...
... evidence to support the link between the common cold ... The study also shows that the link between rhinoviruses ... history of wheezing or asthma. ,Rhinoviruses are ... for at least 50 percent of all common colds. ...
... College of Medicine of Yeshiva University have discovered a ... susceptible to a newly developed molecular targeted therapy. As ... therapy will be able to enroll patients who’ll be ... research was led by Dr. Ari Melnick, assistant professor ...
... about our weight or a bad hair day is ... disorders spend// nearly every waking moment--up to 80 to ... treatment professionals with the Eating Disorders Program at The ... the concern with body shape and size that is ...
... Women’s Health Week will be celebrated May 13-19 this year. ... can take to improve their health. Women often put their ... family members. This week encourages women to be mindful of ... Awareness Day” will be observed on May 15. Sponsored by ...
... According to a report released by International Federation of Red ... by measles//. This disease has so far claimed four lives ... affected by this illness. ,The outbreak began in ... suffering from this infection. There is a steady increase of ...
Cached Medicine News:Health News:CMV Vaccine Prototype Successfully Tested in Guinea Pigs 2Health News:CMV Vaccine Prototype Successfully Tested in Guinea Pigs 3Health News:Children With Asthma Most Affected by Rhinovirus 2Health News:Children With Asthma Most Affected by Rhinovirus 3Health News:Novel Test Identifies Leukemia Patients Likely to Respond to New Therapy 2Health News:Improving Body Image Key to Treating Eating Disorders 2Health News:Improving Body Image Key to Treating Eating Disorders 3Health News:Women’s Health Takes the Spotlight in Ma 2
(Date:11/21/2014)... 2014  The University of Maryland,s A. James Clark ... of the new A. James Clark Hall at the ... cultivate transformative new engineering and biomedical technologies to accelerate ... 10:00 a.m. on November 21 at the site of ... adjacent to the Jeong H. Kim Engineering Building, the ...
(Date:11/21/2014)... Calif. , Nov. 21, 2014 In ... and Performance Scrubs carried out a new product development ... industry,s very first "limited edition" lab coat , ... female professors of surgery in the world. The new ... its unisex predecessors, with a sleek envelope collar, vertical ...
(Date:11/21/2014)... 21, 2014  Heated dialogue in recent months about ... cancer treatments to Gilead,s new hepatitis C drug Harvoni® ... world questioning what it means to put a price ... And while drug pricing is one of the ... both a general business and ethical standpoint – it ...
Breaking Medicine Technology:University of Maryland Breaks Ground for A. James Clark Hall 2University of Maryland Breaks Ground for A. James Clark Hall 3University of Maryland Breaks Ground for A. James Clark Hall 4Medelita Introduces Medical Industry's First Limited Edition Women's Designer Lab Coat 2"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 2"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 3"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 4"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 5
... Corporation (Nasdaq: DRRX ) announced today that ... the BIO CEO & Investor Conference on Monday, February ... being held at the Waldorf-Astoria Hotel in New York ... A live audio webcast of the presentation ...
... BD (Becton, Dickinson and Company) (NYSE: BDX ... that it signed a definitive agreement to acquire Accuri ... and manufactures personal flow cytometers for researchers.  The acquisition ... close during the third quarter of fiscal year 2011. ...
Cached Medicine Technology:DURECT to Present at the BIO CEO & Investor Conference 2BD Announces Agreement to Acquire Accuri Cytometers, Inc. 2BD Announces Agreement to Acquire Accuri Cytometers, Inc. 3
Bandeau Bra...
Post-Surgical compression garments...
... The Albumin Cobalt Binding (ACB®) Test ... Ischemia Modified Albumin (IMA®) by measuring the ... patient serum sample. First identified in the ... albumin comes in contact with ischemic tissue ...
... Binding (ACB®) Test is a clinical chemistry ... by measuring the cobalt binding capacity of ... identified in the early 1990s, IMA is ... with ischemic tissue in the heart. During ...
Medicine Products: